Moores Members Demonstrate Breast Cancer Drug Efficacy for Rare Appendix Cancer
|
Moores Members Andrew Lowy, MD and Shumei Kato, MD are co-senior authors of a publication featured in the Journal of Clinical Oncology that reveals the ability of a breast cancer drug to stabilize tumor growth and reduce blood tumor marker levels in patients with peritoneal mucinous carcinomatosis. This medication provides a new alternative to chemotherapy for patients presenting this rare and often difficult to treat cancer. Learn More >>
|
Moores Member Awarded VA Merit Review Grant
|
Moores Member Michael Bouvet, MD has received this $1.2 million grant for his research on improving the diagnosis and treatment of colorectal cancer through innovative antibody targeting techniques. Congratulations, Dr. Bouvet.
|
UC San Diego Prostate Cancer Patient Summit
|
This event is an opportunity to connect, learn, and share hope in the fight against prostate cancer. Open to patients, caregivers, and advocates, participants can engage in vital discussions, explore cutting-edge research, and help shape the future of prostate cancer care. Learn More & Register >>
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Application Deadline: February 5, 2025
Budget: Not limited | 5 years
|
Application Deadline: February 16, 2025
Budget: $275,000 | 2 years
|
Application Deadline: February 5, 2025
Budget: Not limited | 5 years
|
LOI Deadline: January 24, 2025
Application Deadline: February 24, 2025
Budget: $1.7 million/year | 6 years
|
|
|
The Researcher Spotlight is designed to help you connect with fellow researchers, gain insights into their diverse projects, and discover the paths that led them to their current roles. Uncover a personal touch to their professional achievements, showcasing the varied perspectives within our cancer research community.
|
H. Irene Su, MD, MSCE, is the Associate Director of Equity, Diversity and Inclusion at Moores; as well as a Professor of Obstetrics, Gynecology & Reproductive Sciences, in the Division of Reproductive Endocrinology & Infertility. She is Program Director for the Reproductive Endocrinology & Infertility Fellowship, and Director of the Oncofertility Program at UC San Diego.
|
|
|
| Deep learning artificial intelligence predicts homologous recombination deficiency and platinum response from histologic slides
|
Journal of Clinical Oncology
|
Erik N. Bergstrom, PhD (Structural and Functional Genomics [SFG]), Scott M. Lippman, MD (Cancer Control Program), and Ludmil B. Alexandrov, PhD (SFG)
|
|
|
|
|
Cyclin-dependent kinase 4/6 inhibition as a novel therapy for peritoneal mucinous carcinomatosis with GNAS mutations
|
Journal of Clinical Oncology
|
Jingjing Zou, PhD (Cancer Control Program), Joel Baumgartner, PhD (Solid Tumor Therapeutics [STT]), Rebekah R. White, MD (STT), Gregory P. Botta, MD, PhD (Cancer Biology and Signaling [CBS]), J. Silvio Gutkind, PhD (CBS), Herve Teriac, PhD (STT), Shumei Kato, MD (Structural and Functional Genomics), and Andrew M. Lowy, MD, FACS (STT)
|
|
|
| CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
|
Tyler Stewart, MD (Solid Tumor Therapeutics)
|
|
|
| Mapping extrachromosomal DNA amplifications during cancer progression
|
Vineet Bafna, PhD (Structural and Functional Genomics)
|
| |
COMMUNITY OUTREACH AND ENGAGEMENT (COE)
|
Breast Cancer Awareness Workshop at the Border View YMCA
|
This past Wednesday, COE hosted a special breast cancer awareness workshop at the Border View YMCA. Over 25 attendees joined to learn about risk factors, screening, and other relevant information.
|
|
|
|
